Cost NG - Search Results

1

The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors.

Cost NG, Krabbe LM, Bagrodia A, Margulis V. Cost NG, et al. Curr Opin Urol. 2013 Sep;23(5):411-7. doi: 10.1097/MOU.0b013e32836320a7. Curr Opin Urol. 2013. PMID: 23841980 Review.

2

Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.

Stern JM, Gupta A, Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, Cadeddu JA. Stern JM, et al. BJU Int. 2009 Sep;104(6):786-9. doi: 10.1111/j.1464-410X.2009.08443.x. Epub 2009 Apr 4. BJU Int. 2009. PMID: 19426196

3

Hernia after pediatric urological laparoscopy.

Cost NG, Lee J, Snodgrass WT, Harrison CB, Wilcox DT, Baker LA. Cost NG, et al. J Urol. 2010 Mar;183(3):1163-7. doi: 10.1016/j.juro.2009.11.053. Epub 2010 Jan 22. J Urol. 2010. PMID: 20096869

4

Editorial comment.

Cost NG, Margulis V. Cost NG, et al. J Urol. 2011 Feb;185(2):413; author reply 414. doi: 10.1016/j.juro.2010.09.146. Epub 2010 Dec 17. J Urol. 2011. PMID: 21168168 No abstract available.

5

The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.

Cost NG, Delacroix SE Jr, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. Cost NG, et al. Eur Urol. 2011 Jun;59(6):912-8. doi: 10.1016/j.eururo.2011.02.032. Epub 2011 Feb 23. Eur Urol. 2011. PMID: 21367518

6

Analysis of risk factors for glans dehiscence after tubularized incised plate hypospadias repair.

Snodgrass W, Cost N, Nakonezny PA, Bush N. Snodgrass W, et al. J Urol. 2011 May;185(5):1845-9. doi: 10.1016/j.juro.2010.12.070. Epub 2011 Mar 21. J Urol. 2011. PMID: 21420110

7

Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.

Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V. Youssef RF, et al. Urol Oncol. 2013 Jul;31(5):676-81. doi: 10.1016/j.urolonc.2011.05.006. Epub 2011 Jun 25. Urol Oncol. 2013. PMID: 21704538

8

Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor.

Cost NG, Lubahn JD, Granberg CF, Schlomer BJ, Wickiser JE, Rakheja D, Gargollo PC, Leonard D, Raj GV, Baker LA, Margulis V. Cost NG, et al. Pediatr Blood Cancer. 2012 Jun;58(6):898-904. doi: 10.1002/pbc.23240. Epub 2011 Jul 9. Pediatr Blood Cancer. 2012. PMID: 21744482

9

International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.

Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG. Margulis V, et al. Among authors: cost ng. Eur Urol. 2011 Oct;60(4):673-83. doi: 10.1016/j.eururo.2011.06.042. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21752533 Review.

10

Effect of testicular germ cell tumor therapy on renal function.

Cost NG, Adibi M, Lubahn JD, Romman A, Raj GV, Sagalowsky AI, Margulis V. Cost NG, et al. Urology. 2012 Sep;80(3):641-8. doi: 10.1016/j.urology.2012.04.064. Epub 2012 Jul 26. Urology. 2012. PMID: 22840865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters